â– LECTURE OVERVIEW: Tay-Sachs Disease is a fatal, progressive neurodegenerative lysosomal storage disease categorized as a GM2 gangliosidosis.
â– MOLECULAR GENETICS & HISTOLOGY:
1. Subunit Deletion: Caused by autosomal recessive mutations in the HEXA gene on chromosome 15, which encodes the alpha-subunit of the beta-Hexosaminidase A enzyme.
2. Ganglioside Saturation: Hexosaminidase A is responsible for degrading GM2 gangliosides in lysosomes. When deficient, GM2 ganglioside accumulates progressively to toxic levels in the central and autonomic nervous systems.
3. Neural Cytolysis: Axon tracts and neuronal cell bodies hypertrophy, undergo membrane disruption, and ultimately degenerate.
4. Onion Skin Lysosomes: Electron microscopy reveals classic 'onion skin' or whorled lysosomal configurations containing lipid-rich membrane fragments.
â– EMERGENCY MANAGEMENT:
Acute presentation requires rapid stabilization following standard clinical guidelines. Prioritize securing the airway, maintaining hemodynamic stability, and administering targeted antidotes.
â– EPIDEMIOLOGICAL PROFILE & DENSITY CORRELATIONS:
Global burden patterns reveal notable associations with lifestyle habits, regional environmental factors, and inherited traits.
[HY-BOARD-1348]
🌟 Dynamic Clinical Key:
Tay-Sachs presents in early infancy with developmental regression, hyperacusis (startle response), axial hypotonia, and a hallmark 'cherry-red spot' on fundoscopy (the pale lipid-laden macula framing the normal vascular red fovea). Clinically, it is distinguished from Niemann-Pick by the absolute absence of hepatosplenomegaly. Do not delay emergency interventions for low-priority diagnostic tests. Focus screening efforts on high-risk geographic regions to maximize clinical yield.